Published on Wednesday December 06, 2023

Smooth Drug Development November 2023 News Release

We are working on the following new projects:

  • We won a bidding for an adalimumab trial, phase I.
  • We signed two contracts for medical writing activities for BE trials with Thiocolchicoside.

We are happy to reach the following milestones in our projects:

  • CTA was received in a Liraglutide trial.
  • 11 patients were randomized in a phase III clinical trial in paroxysmal nocturnal hemoglobinuria.
  • 1224 subjects are enrolled in the observational program of multivitamins in pregnant and childbearing women. CTA for additional sites in Uzbekistan was received.
  • 320 subjects finished treatment in the Adezmapimod + Vimdemer trial in adhesions during surgeries.